Ivania Rizo MD
Clinical Associate Professor, Endocrinology, Diabetes, Nutrition & Weight Management
720 Harrison Ave | (617) 638-8638ivamrizo@bu.edu
ivania.rizo@bmc.org
Sections
Endocrinology, Diabetes, Nutrition & Weight Management
Biography
Dr. Rizo specializes in obesity medicine, diabetes, and cardiometabolic health equity. Her research focuses on obesity medicine, post-bariatric weight regain, cardiometabolic health equity and the social determinants of health. Following a national search, Dr. Rizo was appointed director of obesity medicine at Boston Medical Center (BMC) in 2021. In 2025, she was named co-medical director of the Endocrinology, Diabetes, Nutrition & Weight Management Clinic. She also serves as diabetes clinical co-lead for BMC's Health Equity Accelerator, where she develops programs to improve equity in diabetes care in high-risk populations at BMC. In addition, Dr. Rizo is the endocrinology lead for Heart of Communities, a collaboration among BMC, Mass General Brigham and Mattapan Community Health Center focused on improving cardiovascular, kidney and metabolic health in the Mattapan community.
Her clinical and academic interests include obesity, diabetes, and cardiovascular–kidney–metabolic disease. She is triple board-certified in Internal Medicine, Endocrinology, and Obesity Medicine, and is an active member of the Endocrine Society, the American Diabetes Association, and The Obesity Society.
Education
Physiology, MD, Georgetown University
Physiology, BS, University of Maryland
Publications
Bassatne A, Rizo I. Future Directions in the Medical Treatment of Obesity: A Narrative Review. Adv Ther. 2026 Jun; 43(6):2387-2407. PMID: 41954863.
Published on 6/6/2025Campos A, Fantasia KL, Rizo I. Knowledge, attitudes, and practices in obesity among trained and in-training primary care providers in an urban safety-net hospital system. Obes Pillars. 2025 Sep; 15:100185. PMID: 40546447.
Published on 4/25/2025Mohanty A, Austad K, Bosch NA, Long MT, Nolen-Doerr E, Walkey AJ, Drainoni ML, Rizo I, Fantasia KL. Assessing Clinician Engagement With a Passive Clinical Decision Support System for Liver Fibrosis Risk Stratification in a Weight Management Clinic. Endocr Pract. 2025 Jul; 31(7):899-905. PMID: 40288606.
Published on 8/15/2022Ryan TJ, Heyman AS, Mulvey EN, McLaughlin A, Rizo IM, Assoumou SA. Factors associated with inpatient complications among patients with obesity and COVID-19 at an urban safety-net hospital: A retrospective cohort study. Obes Sci Pract. 2022 Aug 15; 8(6):794-800. PMID: 35938065.
Published on 3/10/2021Fantasia KL, Wirunsawanya K, Lee C, Rizo I. Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital. J Diabetes Sci Technol. 2021 09; 15(5):1010-1017. PMID: 33719610.
Published on 9/1/2019Nolen-Doerr E, Stockman MC, Rizo I. Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity. Curr Obes Rep. 2019 Sep; 8(3):284-291. PMID: 31124035.
Published on 6/7/2019Dupepe E, Patel D, Miller J, Rizo I, Vaughan TB, Riley K. Postoperative day 1 versus postoperative day 5 morning cortisol for predicting an intact hypothalamic-pituitary axis: A cohort analysis. Surg Neurol Int. 2019; 10:91. PMID: 31528429.
Published on 1/15/2019Rizo IM, Apovian CM. Diabetic Ketoacidosis Post Bariatric Surgery. Front Endocrinol (Lausanne). 2018; 9:812. PMID: 30697192.
Published on 6/29/2018Rodriguez-Diaz E, Rizo I, Sullivan C, Steenkamp DW. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity. J Diabetes Sci Technol. 2018 11; 12(6):1239-1240. PMID: 29957042.
Published on 8/1/2002Hotez PJ, Ashcom J, Bin Z, Bethony J, Williamson A, Hawdon JM, Jianjun F, Dobardzic A, Rizo I, Bolden J, Jin Q, Yan W, Dobardzic R, Chung-Debose S, Crowell M, Datu B, Delaney A, Dragonovski D, Jiang Y, Yueyuan L, Ghosh K, Loukas A, Brandt W, Russell PK, Zook BC. Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. J Parasitol. 2002 Aug; 88(4):684-90. PMID: 12197114.
Media Mentions
Published on 10/3/2025
Published on 8/22/2024
Will Compounding 'Best Practices' Guide Reassure Clinicians?
Published on 8/21/2024
Will Compounding 'Best Practices' Guide Reassure Clinicians?
Published on 1/19/2024
These Drugs Are Changing the Fight against Obesity
Published on 10/16/2023
Tirzepatide Provides 'Meaningful' Weight Loss in SURMOUNT-3
Published on 10/5/2023
Published on 7/21/2023
Water Fasting: Is It Safe? Is It for You?
Published on 7/12/2023
Can Berberine Live Up to the Claim That It's 'Nature's Ozempic'?
Published on 7/12/2023
Can Berberine Live Up to the Claim That It's 'Nature's Ozempic'?
Published on 8/8/2022
Obesity Drug Shortage Triggers Frustrations, Workarounds
View full list of 12 media mentions.